Lundbeck presents research programme and perspectives on future treatment opportunities in stroke

The current issue of Nature includes a supplement on stroke sponsored by Lundbeck. Lundbeck presents in a sponsor feature its current research in the field and future treatment perspectives, particularly for acute ischaemic stroke (AIS).

For AIS patients who are admitted in hospital after the time window for thrombolysis has expired, the only clot-targeting therapy is mechanical clot removal, also known as thrombectomy. Thrombectomy is, however, considered experimental and future use of it may be limited, because it requires highly specialized hospital facilities and staff, significantly adding to the cost of treatment.

Lundbeck’s stroke research aims to extend the time window in which AIS patients can receive effective recanalization and reperfusion therapy, and thereby increase the number of patients who can be offered thrombolytic treatment.

Because treatment options are limited, there is a need to develop new stroke treatments, which should be easy to implement despite differences in countries’ health systems and infrastructure. This effort should be coordinated with campaigns to educate the public on how to recognize and react to stroke symptoms, and efforts to reduce exposure to the key modifiable risk factors for stroke.

Read the Outlook supplement and sponsor feature in full on Nature.com.

Download the white paper

About stroke

Stroke is a medical emergency which results from a sudden disruption in blood flow to the brain, caused either by obstruction of an artery (ischaemic stroke) or bleeding from an intracranial blood vessel (haemorrhagic stroke). It is the second-leading cause of death and the third-leading cause of disability-adjusted life years lost globally. The majority (80–85%) of all stroke events are ischaemic, also called acute ischaemic stroke (AIS). Only a minority of AIS patients receive clot-targeting treatment despite the progress made in the field in the previous two decades.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.